These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28329801)

  • 1. Compact Magnetic Resonance Imaging Systems-Novel Cost-Effective Tools for Preclinical Drug Safety and Efficacy Evaluation.
    Ramot Y; Schiffenbauer YS; Maronpot R; Nyska A
    Toxicol Sci; 2017 May; 157(1):3-7. PubMed ID: 28329801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Applications of in Vivo and ex Vivo MRI in Toxicologic Pathology Using a Novel High-performance Compact MRI System.
    Tempel-Brami C; Schiffenbauer YS; Nyska A; Ezov N; Spector I; Abramovitch R; Maronpot RR
    Toxicol Pathol; 2015 Jul; 43(5):633-50. PubMed ID: 25694086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity Studies.
    Maronpot RR; Nyska A; Troth SP; Gabrielson K; Sysa-Shah P; Kalchenko V; Kuznetsov Y; Harmelin A; Schiffenbauer YS; Bonnel D; Stauber J; Ramot Y
    Toxicol Pathol; 2017 Jun; 45(4):444-471. PubMed ID: 28641506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput magnetic resonance imaging in mice for phenotyping and therapeutic evaluation.
    McConville P; Moody JB; Moffat BA
    Curr Opin Chem Biol; 2005 Aug; 9(4):413-20. PubMed ID: 16002325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the "epigenetic end points in toxicologic pathology and relevance to human health" session of the 2014 Society Of Toxicologic Pathology Annual Symposium.
    Hoenerhoff MJ; Hartke J
    Toxicol Pathol; 2015 Jan; 43(1):98-100. PubMed ID: 25330923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost versus efficacy of magnetic resonance imaging.
    Khangure MS; Ives FJ
    Aust Fam Physician; 1995 Apr; 24(4):538-9, 541, 543 passim. PubMed ID: 7771959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    Eaton JS; Miller PE; Bentley E; Thomasy SM; Murphy CJ
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):718-734. PubMed ID: 29239680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging (MRI): a new tool in experimental toxicologic pathology.
    Dixon D; Johnson GA; Cofer GP; Hedlund LW; Maronpot RR
    Toxicol Pathol; 1988; 16(3):386-91. PubMed ID: 3194661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine magnetic resonance imaging for idiopathic olfactory loss: a modeling-based economic evaluation.
    Rudmik L; Smith KA; Soler ZM; Schlosser RJ; Smith TL
    JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):911-7. PubMed ID: 25211179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low-cost, high-field-strength magnetic resonance imaging-compatible actuator.
    Secoli R; Robinson M; Brugnoli M; Rodriguez y Baena F
    Proc Inst Mech Eng H; 2015 Mar; 229(3):215-24. PubMed ID: 25833997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
    de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
    Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tools of the trade for cost-effective MRI.
    Bell RA
    Diagn Imaging (San Franc); 1997 Apr; 19(4):49-52. PubMed ID: 10168528
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies.
    Hornberg JJ; Laursen M; Brenden N; Persson M; Thougaard AV; Toft DB; Mow T
    Drug Discov Today; 2014 Aug; 19(8):1137-44. PubMed ID: 24374152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
    Johnson N; Sorenson L; Bennetts L; Winter K; Bryn S; Johnson W; Glissmeyer M; Garreau J; Blanchard D
    Am J Surg; 2014 May; 207(5):698-701; discussion 701. PubMed ID: 24791629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of investigative toxicology in the pharmaceutical industry.
    Pognan F; Beilmann M; Boonen HCM; Czich A; Dear G; Hewitt P; Mow T; Oinonen T; Roth A; Steger-Hartmann T; Valentin JP; Van Goethem F; Weaver RJ; Newham P
    Nat Rev Drug Discov; 2023 Apr; 22(4):317-335. PubMed ID: 36781957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomics in the preclinical and environmental toxicity field.
    Colet JM
    Drug Discov Today Technol; 2015 Jun; 13():3-10. PubMed ID: 26190677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why buy an expensive ($7 million) 7T MRI system for biomedical research?
    Regatte RR
    J Magn Reson Imaging; 2014 Aug; 40(2):280-2. PubMed ID: 24123421
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonclinical Safety and Toxicology.
    Stark C; Steger-Hartmann T
    Handb Exp Pharmacol; 2016; 232():261-83. PubMed ID: 26489827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of the status of magnetic resonance imaging in health care.
    Hailey D
    J Qual Clin Pract; 1997 Dec; 17(4):221-30. PubMed ID: 9427193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.